Cargando…
Liposome-Fe(3) O(4)-Doxorubicin Mediated Treatment of Melanoma Tumors
Purpose: Magnetic hyperthermia is a treatment method based on eddy currents, hysteresis, and relaxation mechanisms of magnetic nanoparticles (MNPs). MNPs such as Fe(3) O(4) have the ability to generate heat under an alternating magnetic field. Heat sensitive liposomes (Lip) convert from lipid layer...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278224/ https://www.ncbi.nlm.nih.gov/pubmed/37342384 http://dx.doi.org/10.34172/apb.2023.034 |
_version_ | 1785060437983756288 |
---|---|
author | Azlegini, Azalia Javadpour, Sirus Bahrololoom, Mohamad Ebrahim |
author_facet | Azlegini, Azalia Javadpour, Sirus Bahrololoom, Mohamad Ebrahim |
author_sort | Azlegini, Azalia |
collection | PubMed |
description | Purpose: Magnetic hyperthermia is a treatment method based on eddy currents, hysteresis, and relaxation mechanisms of magnetic nanoparticles (MNPs). MNPs such as Fe(3) O(4) have the ability to generate heat under an alternating magnetic field. Heat sensitive liposomes (Lip) convert from lipid layer to liquid layer through heat generated by MNPs and can release drugs. Methods: In this study, different groups of doxorubicin (DOX), MNPs and liposomes were evaluated. The MNPs were synthesized by co-precipitation method. The MNPs, DOX and a combination of MNPs and DOX were efficiently loaded into the liposomes using the evaporator rotary technique. Magnetic properties, microstructure, specific absorption rate (SAR), zeta potential, loading percentage of the MNPs and DOX concentration in liposomes, in vitro drug release of liposomes were studied. Finally, the necrosis percentage of cancer cells in C57BL/6J mice bearing melanoma tumors was assessed for all groups. Results: The loading percentages of MNPs and concentration of DOX in the liposomes were 18.52 and 65% respectively. The Lip-DOX-MNPs at the buffer citrate solution, showed highly SAR as the solution temperature reached 42°C in 5 minutes. The release of DOX occurred in a pH-dependent manner. The volume of tumor in the therapeutic groups containing the MNPs significantly decreased compared to the others. Numerical analysis showed that the tumor volume in mice receiving Lip-MNPs-DOX was 9.29% that of the control and a histological examination of the tumor section showed 70% necrosis. Conclusion: The Lip-DOX-MNPs could be effective agents which reduce malignant skin tumors growth and increase cancer cell necrosis. |
format | Online Article Text |
id | pubmed-10278224 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Tabriz University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-102782242023-06-20 Liposome-Fe(3) O(4)-Doxorubicin Mediated Treatment of Melanoma Tumors Azlegini, Azalia Javadpour, Sirus Bahrololoom, Mohamad Ebrahim Adv Pharm Bull Research Article Purpose: Magnetic hyperthermia is a treatment method based on eddy currents, hysteresis, and relaxation mechanisms of magnetic nanoparticles (MNPs). MNPs such as Fe(3) O(4) have the ability to generate heat under an alternating magnetic field. Heat sensitive liposomes (Lip) convert from lipid layer to liquid layer through heat generated by MNPs and can release drugs. Methods: In this study, different groups of doxorubicin (DOX), MNPs and liposomes were evaluated. The MNPs were synthesized by co-precipitation method. The MNPs, DOX and a combination of MNPs and DOX were efficiently loaded into the liposomes using the evaporator rotary technique. Magnetic properties, microstructure, specific absorption rate (SAR), zeta potential, loading percentage of the MNPs and DOX concentration in liposomes, in vitro drug release of liposomes were studied. Finally, the necrosis percentage of cancer cells in C57BL/6J mice bearing melanoma tumors was assessed for all groups. Results: The loading percentages of MNPs and concentration of DOX in the liposomes were 18.52 and 65% respectively. The Lip-DOX-MNPs at the buffer citrate solution, showed highly SAR as the solution temperature reached 42°C in 5 minutes. The release of DOX occurred in a pH-dependent manner. The volume of tumor in the therapeutic groups containing the MNPs significantly decreased compared to the others. Numerical analysis showed that the tumor volume in mice receiving Lip-MNPs-DOX was 9.29% that of the control and a histological examination of the tumor section showed 70% necrosis. Conclusion: The Lip-DOX-MNPs could be effective agents which reduce malignant skin tumors growth and increase cancer cell necrosis. Tabriz University of Medical Sciences 2023-03 2022-01-02 /pmc/articles/PMC10278224/ /pubmed/37342384 http://dx.doi.org/10.34172/apb.2023.034 Text en ©2023 The Authors. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, as long as the original authors and source are cited. No permission is required from the authors or the publishers. |
spellingShingle | Research Article Azlegini, Azalia Javadpour, Sirus Bahrololoom, Mohamad Ebrahim Liposome-Fe(3) O(4)-Doxorubicin Mediated Treatment of Melanoma Tumors |
title | Liposome-Fe(3) O(4)-Doxorubicin Mediated Treatment of Melanoma Tumors |
title_full | Liposome-Fe(3) O(4)-Doxorubicin Mediated Treatment of Melanoma Tumors |
title_fullStr | Liposome-Fe(3) O(4)-Doxorubicin Mediated Treatment of Melanoma Tumors |
title_full_unstemmed | Liposome-Fe(3) O(4)-Doxorubicin Mediated Treatment of Melanoma Tumors |
title_short | Liposome-Fe(3) O(4)-Doxorubicin Mediated Treatment of Melanoma Tumors |
title_sort | liposome-fe(3) o(4)-doxorubicin mediated treatment of melanoma tumors |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278224/ https://www.ncbi.nlm.nih.gov/pubmed/37342384 http://dx.doi.org/10.34172/apb.2023.034 |
work_keys_str_mv | AT azleginiazalia liposomefe3o4doxorubicinmediatedtreatmentofmelanomatumors AT javadpoursirus liposomefe3o4doxorubicinmediatedtreatmentofmelanomatumors AT bahrololoommohamadebrahim liposomefe3o4doxorubicinmediatedtreatmentofmelanomatumors |